Search Results for john rogers

The Theranos Story, ch. 49: CEO Holmes reportedly raising funds for a new company–and feeling like Joan of Arc

[grow_thumb image=”http://telecareaware.com/wp-content/uploads/2016/11/jacobs-well-texas-woe1.jpg” thumb_width=”150″ /]Here’s the place where your money will go if you’re an investor. John Carreyrou has now compiled his reporting for the Wall Street Journal on Theranos into a new book, Bad Blood: Secrets and Lies in a Silicon Valley Startup, and it is a Must Read for this Editor and anyone interested in the nexus of Tech, Healthcare, and Hype. (The link goes to AbeBooks, a worthy marketplace for independent booksellers.) According to Mr. Carreyrou, the founder/CEO Miss Elizabeth Holmes–still leading the company despite settling with the SEC on fraud charges, surrendering her voting control, barred from... Continue Reading

Hungary’s burgeoning med and health tech scene comes to NYC

...early-stage companies participating in the V4 Connects Global Tour business showcase. The Visegrad Group (the V4) are four Central European countries within the EU–Hungary (this year’s president), Poland, the Czech Republic, and the Slovak Republic–that have worked together since 1991 to promote their regional interests. The evening led off with a discussion panel led by Goodwin’s Frederick Rein, a partner in their IP Litigation Group, with Scott Lassman from their Technology & Life Sciences Group and Peter Takacs, Director Real World Evidence Partnership in the Global Market Access Organization of the Janssen Pharmaceutical Companies of Johnson & Johnson. Most of... Continue Reading

The Theranos Story, ch. 48: down to 24 employees in a last ditch before bankruptcy

...WSJ article from the estimable John Carreyrou (who deserves an old-school Pulitzer Prize for his investigative reporting) recaps Theranos’ fall for those who need it. But…there’s more. Theranos received only $65 million of $100 million promised in their last (ditch) funding from Fortress Investment Group late last year, revealed by Ms. Holmes in an investor email this past Tuesday. The remainder is contingent on Theranos achieving an FDA Zika blood test approval using their miniLab. She stated that this test is still having problems and appealed to investors for yet more funding. The layoffs were designed to keep their cash... Continue Reading

Butterfly IQ handheld ultrasound offers clinical-quality body imaging for under $2,000

...$2,000, far under other handhelds or carts (VScan is above $12,000, Lumify about $6,000), with delivery this year (pre-order notification at present) in the US only. Butterfly is also working on problems such as the volume of blood a heart is pumping or detecting problems like aortic aneurysms. The IQ has a brace of impressive testimonials from doctors at Yale, UC Irvine, Denver Health, Rocky Vista University, Mass General, St. Elizabeth’s (Boston), and Metrowest Medical Center. According to vascular surgeon and company chief medical officer Dr. John Martin, he used it on himself to diagnose a mass in his neck... Continue Reading

Blockchains, EHRs, roadblocks and baby steps

John Boden But of course, Steve would be the one to actually understand Blockchain, and even more impressively, be able to have me finally get my arms around the concept in my pea brain. Thank you, Steve. John Boden Steve Hards You are too kind John. I'm glad it has helped someone! Greg Buis It also helped my little brain as well. Thank you Mr. Hards, particularly since I recently encountered Estonia in my DNA profile!.... Continue Reading

Retail health convergence and ‘Amazon Effect’ continues with Albertsons’ acquisition of Rite Aid (updated)

...present Albertson shareholders over 70 percent. Another benefit for Albertsons–it’s a quick and easy way to go public without an IPO using Rite Aid’s public status to effect a reverse takeover merger. It solves for Rite Aid (and Walgreens) the large problem of the unsold Rite Aid stores. Albertsons’ 2,200 supermarkets are in 38 states and the District of Columbia and comprise multiple brands such as Safeway and Acme in addition to Albertsons. Rite Aid stand-alone stores will continue to operate under their brand name as will most in-store pharmacies. The Rite Aid CEO John Standley will become CEO of... Continue Reading

How do digital health partnerships happen? Where do you go with them? Views from a developer and an app security provider.

This Editor recently covered a partnership between Doncaster UK’s MediBioSense Ltd.and San Francisco-based Blue Cedar, where Blue Cedar’s app security system will protect information from MediBioSense’s app through to the provider database. I was curious how two physically distant small companies, even in this global healthcare business, found each other, as well as how MediBioSense (MBS) adopted a US-developed sensor from VitalConnect. To find out more, I spoke with the company CEOs, Simon Beniston of MBS and John Aisien of Blue Cedar. Their respective experiences led me to three takeaways which are applicable to early-stage companies–wherever they are located. Past... Continue Reading

The UTOPIA Project evaluation of telecare in social care report published (UK)

...percent). We will happily note that our own Editor Charles Lowe and three of his TTA articles on the WSD were included in the UTOPIA Project references (see page 8 and footnotes on pages 51-52): Is this the last time the flat earth society will be celebrating?, Soapbox: Further thoughts on CarelineUK, O2 & WSD, and Telehealth Soapbox: Time to bid farewell to the WSD? A free copy of the 59-page UTOPIA Project ‘output’ is available for PDF download from the King’s College London website here. The authors are John Woolham, King’s College London; Nicole Steils, King’s College London; Malcolm... Continue Reading

The Theranos Story, ch. 45: a ‘Christmas present’ $100 million loan from Fortress averts bankruptcy (updated 8 Jan)

[grow_thumb image=”http://telecareaware.com/wp-content/uploads/2016/11/jacobs-well-texas-woe1.jpg” thumb_width=”150″ /]A present or a Trojan Horse? Revealed on Christmas Eve by the intrepid John Carreyrou of the Wall Street Journal (paywalled) is Theranos’ securing of a $100 million loan from Fortress Investment Group LLC. This Editor notes the word ‘loan’, and loans come with conditions. Mr. Carreyrou revealed that according to an email sent by (unbelievably still in place) CEO Elizabeth Holmes on Friday 22 December and reviewed by the WSJ, it is “subject to achieving certain product and operational milestones.” As our Readers know, with the Walgreens Boots settlement in August, cash on hand from June... Continue Reading

CVS’ bid for Aetna–will it happen, and kick off a trend? (updated)

...Bright Health….or seeking alliances? And then, there’s Amazon and Whole Foods….no pharmacy in-house at Whole Foods, but talk about a delivery system? Also Chicago Tribune, MedCityNews. UPDATED. In seeking an update for the Anthem-Cigna ‘Who Shot John’ court action about breakup fees (there isn’t yet), this Editor came across a must-read analysis in Health Affairs by David Dranove, DOJ’s economics expert, about the arguments underpinning the DOJ and court denial of the merger. Retailer-payer mergers will likely avoid the market dominance argument that doomed the previous round of insurer mergers. But, if any of these negatively affect “national accounts” employers... Continue Reading